Nath Bio-Genes (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Nath Bio-Genes (India) Ltd · Financial Result · 14 Nov 2026, 10:43 pm
Nath Bio-Genes (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 4,074 (-7.1% YoY | -87.6% QoQ) ■ EBITDA: 464 (-24.1% YoY | -86.8% QoQ) ■ EBITDA Margin (%): 11.4 (-254 bps YoY | +67 bps QoQ) ■ PAT: 41.9 (-84.8% YoY | -98.7% QoQ) ■ EPS (INR): 0.22 (-84.8% YoY | -98.7% QoQ)
Original exchange filing (PDF)
More announcements from Nath Bio-Genes (India) Ltd
- Audio Transcript of Conference Call held on 16th November 2026 · 17 Nov 2026
- Presentation on Unaudited Financial Results as of 30th September 2026 · 16 Nov 2026
- Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Intimation about Conference call to be held on 16th November 2026 at 04:00 PM · 16 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- NATH BIO-GENES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 14 Nov 2026
- Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited financial .... · 14 Nov 2026
- Proceedings of AGM and Scrutinizers report for AGM held on 24th September 2026 · 24 Sept 2026
